Soleus Capital Management »

Merus N V shares owned by Soleus Capital Management

Quarter-by-quarter ownership of Merus N V (MRUS) shares owned by Soleus Capital Management from 13F filings

Historical chart of Soleus Capital Management investment in Merus N V

Tip: Access up to 7 years of quarterly data

All positions including Merus N V held by Soleus Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Merus N V by Soleus Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $8.3M 303k 27.50
2023-09-30 $9.1M 385k 23.58

More positions owned by Soleus Capital Management

Teva Pharmaceutical Inds Sponsored Ads (TEVA)
United Therapeutics Corporation (UTHR)
GSK Sponsored Adr (GSK)
Rayzebio
Edap Tms S A Sponsored Adr (EDAP)
Organogenesis Hldgs (ORGO)
Humana (HUM)
Celcuity (CELC)
Iradimed (IRMD)
Essa Pharma Com New (EPIX)
SurModics (SRDX)
Hca Holdings (HCA)
Vaxcyte (PCVX)
Neuropace (NPCE)
Nuvalent Inc-a (NUVL)

View all positions for Soleus Capital Management

Top funds holding Merus N V

Commodore Capital
Federated Investors
Samlyn Capital
Deerfield Management Company
BVF
VR Adviser
Wellington Management Company
Boxer Capital
Franklin Resources
Balyasny Asset Management
Medicxi Ventures Management
Lynx1 Capital Management
venBio Select Advisor
Frazier Life Sciences Management
Fairmount Funds Management

View all funds holding Merus N V